Jennifer Carew, PhD

Associate Professor, Medicine
Co-Director, Hematologic Malignancy Disease Team
Email Address: 
Phone Number: 
(520) 626-2272
Professional Bio: 
  • Translational cancer researcher with expertise in experimental cancer therapeutics, mechanisms of cell death and drug resistance, in vitro and in vivo preclinical investigation of developmental cancer therapeutics, Phase I clinical trial design, and clinical trial correlates
  • 15 years of research experience in basic and translational hematology and oncology
  • 6 years of experience as the Co-Director of a contract research organization laboratory evaluating the preclinical activity and mechanism of action of novel cancer therapeutics in cell lines, primary patient specimens, and mouse models of cancer
  • Track record of strong industry collaborations focused on investigational drugs, strategies to translate preclinical findings into clinical trials, and development of rational correlative studies in support of clinical trials
  • Patent inventor of novel anticancer agents

Research Information

Selected Publications: 

Professional Information

Positions and Honors: 
  • Leukemia and Lymphoma Society Scholar, 2012
  • Voelcker Fund Young Investigator Award, 2012
  • Leukemia Texas Young Investigator Award, 2008
  • American Cancer Society Postdoctoral Research Award, 2007
  • Sowell-Huggins Endowed Scholarship for Cancer Research, 2005
  • University of Texas Health Science Center and M.D. Anderson Cancer Center Presidents’ Research
  • Scholarship, 2005
  • American Legion Auxiliary Fellowship for Cancer Research, 2003-2005
  • Shell Oil Foundation Scholarship for Excellence in Toxicology Research, 2003
  • Edward S. Reynolds Award for Best Platform Presentation, Gulf Coast Society of Toxicology Annual
  • Meeting, 2003
  • Gulf Coast Society of Toxicology Travel Award, 2003
  • Society of Toxicology Travel Award, 2003
Other Experience and Professional Memberships/Affiliations: 
PATENTS
US Patent #8,524,762 B2 – Thioxanthone-based autophagy inhibitor therapies to treat cancer
US Patent Filed 07/2014 – Novel autophagy inhibitors for cancer therapy
 
AFFILIATIONS
American Association for Cancer Research
American Society of Hematology
European Hematology Association

Academic Information

Doctorate: 
Biomedical Sciences, University of Texas M.D. Anderson Cancer Center, Houston, Tx
Undergraduate School: 
BS, Zoology, University of Wisconsin – Madison